Oct 27, 2026· Comment from Alliance for Pharmacy Compounding and National Community Pharmacists Association· FDA-2026-N-5479-2255
Comments from The Alliance for Pharmacy Compounding and the National Community Pharmacists Association
FDANonrulemakingFDA-2026-N-5479
Testosterone Use in Menopausal Women; Public Workshop
RIN
—
Last modified
Oct 27, 2026
Comment window
closed 17d ago
National Community Pharmacists Association filings
1
Activity
National Community Pharmacists Association filed 1 comment on this docket between Oct 27, 2026 and Oct 27, 2026. 12 other organizations filed here. The comment window closed 17d ago.
What National Community Pharmacists Association filed (1)
Abstract
OPEN
View on regulations.gov →Co-filers (12)
See everyone who commented →- National Community Pharmacists AssociationTHIS ORG1 filing · confidence 97%
- Acrux DDS Pty Ltdunverified attribution1 filing · confidence 70%
- Adelaide Universityunverified attribution1 filing · confidence 70%
- Ailse Oncology Ltd.unverified attribution1 filing · confidence 70%
- American Association of Clinical Endocrinologytrade assoc.1 filing · confidence 85%
- Health Without Risk LLCunverified attribution1 filing · confidence 70%
- Hims & Hers Health Inc.unverified attribution1 filing · confidence 70%
- International Society for the Study of Women's Sexual Healthtrade assoc.1 filing · confidence 85%
- LIPOCINE INC.unverified attribution1 filing · confidence 70%
- PharmedOut at Georgetown University Medical Centerunverified attribution1 filing · confidence 70%
- RRM Foundationtrade assoc.1 filing · confidence 85%
- The Netherlands Association for Women's Intereststrade assoc.1 filing · confidence 85%
- The Netherlands Association for Women's Interests Women's Work and Equal Citizenshiptrade assoc.1 filing · confidence 85%